A cost-effective and sensitive TLC-densitometric identification of meloxicam by WIOLETTA PARYS et al.
143
Acta Pharm. 71 (2021) 143–152 Short communication
https://doi.org/10.2478/acph-2021-0006
A cost-effective and sensitive TLC-densitometric 
identification of meloxicam
The influence of different chromatographic conditions and 
the process of spot visualization on determining the limit 
of detection as well as quantification (LOD and LOQ) of 
meloxicam by TLC-densitometric technique was estimated. 
Of all chromatographic conditions tested, the lowest limit-
ing values, thus the best sensitivity, in the NP-TLC system 
was achieved on silica gel 60F254 and neutral aluminum 
oxide plates developed with the mobile phase consisting of 
ethyl acetate/toluene/n-butylamine (2:2:1, V/V/V). In the 
case of the RP-TLC method, a mixture of methanol/water 
(8:2, V/V) enabled densitometric detection of meloxicam at 
the lowest concentration level on RP-8F254 and RP-18F254 
plates. Additionally, the smallest LOD value of meloxicam 
ensured crystalline violet and gentian violet as visualiza-
tion agents on silica gel 60F254 and neutral aluminum oxide 
150F254 plates, resp. Comparison of the densitometrically 
obtained spectra of meloxicam drug and its standard after 
the use of appropriate visualization agents could be a good 
and cheap alternative tool for the identification of meloxi-
cam as an active pharmaceutical ingredient.
Keywords: meloxicam, TLC-densitometry, identification, 
sensitivity, visualization agents
Rheumatoid diseases belong to the most common diseases of the musculoskeletal 
system and connective tissues, especially in developed countries. They are one of the big-
gest issues of today’s medicine due to the large number of people suffering from these 
diseases as well as their consequences. Non-steroidal anti-inflammatory drugs (NSAIDs), 
both traditional non-steroidal drugs and cyclooxygenase-2 inhibitors, are often used to 
treat patients with pain and inflammation. NSAIDs are very effective painkillers and one 
of the cornerstones of pain management in patients with arthritis (1). For example, meloxi-
cam is a heterocyclic compound that belongs to the group of NSAIDs with a strong anal-
gesic, anti-inflammatory and antipyretic effect. It is also a selective COX-2 blocking agent. 
During its use, the side-effects are less frequent and smaller compared to the drugs that 
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The detection of various drugs by TLC was described in our earlier articles (2, 3). An 
extensive literature review reveals that till today the TLC detection of meloxicam on chroma-
tographic plates is most often carried out under UV light without any visualization agent 
(4–11). To the best of our knowledge, there are no literature reports concerning the use of 
visualization agents to detect meloxicam on a thin-layer. Therefore, in this work, the utility 
of selected dyes as potential new visualization agents for the identification of meloxicam as 
a drug substance was also shown.
EXPERIMENTAL
Chemicals and reagents
The reference standard of meloxicam was procured from Sigma-Aldrich (USA). Organic 
solvents of analytical grade supplied by POCh (Poland) such as methanol, ethyl acetate, tolu-
ene, ethanol (96 %) and N,N-dimethylformamide, as well as n-buthylamine (Acros Organics, 
Belgium) were applied as the components of mobile phases and as solvents for meloxicam.
Chromatographic plates
Planar chromatography was performed on the following TLC plates purchased from 
Merck (Germany), TLC aluminum sheets (10 × 20 cm) precoated with: (i) neutral aluminum 
oxide 60F254 (Al2O3 60F254), (ii) neutral aluminum oxide 150F254 (Al2O3 150F254), (iii) silica gel 
60 (SiO2 60), (iv) silica gel 60F254 (SiO2 60F254), (v) mixture of silica gel 60 and Kieselguhr 60F254 
(SiO2 60/KG F254), (vi) silica gel RP-18F254 (SiO2 RP-18F254). Also, TLC glass plates precoated 
with silica gel RP-8 F254 (SiO2 RP-8F254) were used.
Instrumentation
TLC Scanner 3 manufactured by Camag (Switzerland) was used in the reflectance/ 
absorbance mode and controlled by WinCATS software (version 1.4.2) for spectrodensito-
metric and densitometric scanning, a twin-trough glass chamber (20 × 10 cm, Camag) was 
applied for the development of chromatographic plates and 5-mL microliters pipettes 
 (Camag) were utilized for spotting the solutions of meloxicam.
Preparation of sample solutions
Working standard solutions of meloxicam were prepared in a mixture of methanol and 
N,N-dimethylformamide as a solvent (1:1, V/V) in the following concentrations: 1.60, 1.40, 
1.20, 1.00, 0.80, 0.60, 0.40, 0.25, 0.20, 0.18, 0.16, 0.14, 0.12, 0.10, 0.08, 0.06, 0.04, and 0.02 
mg mL–1. The spot volume was 5 µL.
Chromatographic conditions
Different types of chromatographic plates as mentioned in the previous section were 
tested in TLC analysis of meloxicam in both, i.e., normal-phase and reversed-phase system. 
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In the case of adsorption TLC, the plates were pre-washed with methanol and then acti-
vated at 120 °C for 30 min prior to chromatographic analysis. After sample application, the 
plates were developed in a Camag twin-trough chamber pre-saturated with mobile phase 
vapor for 30 min at the room temperature, up to 75 mm, using two mixtures: ethyl acetate/
toluene/n-butylamine (2:2:1, V/V/V) (mobile phase I) and ethyl acetate/ethanol/toluene/25 % 
NH4OH (6:3:1:0.06, V/V/V/V) (mobile phase II). For the RP-TLC study, a mixture of methanol 
and water in a volume ratio of 5:5 (mobile phase III) and 8:2 (mobile phase IV) were used. 
After development, the plates were dried at room temperature (20 ± 2 °C) for 24 h. In the 
next step, the plates were directly scanned densitometrically or after the treatment with 
an appropriate visualization agent. All analyses were repeated six times. Averages were 
 calculated from the results obtained.
Visualization agents
Processes of spot visualization were carried out using several visualization agents 
procured from different suppliers. The solutions of these reagents were prepared as fol-
lows: 
–  (i) rhodamine B (POCh), (ii) Janus blue (Michrom, UK), (iii) methyl green (Fluka, 
Switzerland), (iv) brilliant green (POCh), (v) crystalline violet (Sigma-Aldrich), (vi) 
alkaline blue (Merck), (vii) gentian violet (Fluka), and (viii) methylene violet (Mi-
chrom) were used as 0.50 mg mL–1 solutions in distilled water,
–  fuchsine procured from Serva (Germany) was used as 0.150 mg mL–1 solution in 
distilled water,
–  brilliant cresyl blue supplied by Michrom was used as 0.50 mg mL–1 solution in 2 % 
aqueous NaOH. 
Taking into account the visualization manner, all obtained chromatograms have been 
divided into four groups. The first group was dipped in an individual visualization agent 
for 5 s and then left at room temperature until dry. The second group was immersed in an 
individual visualization agent for 5 s and then dried in a laboratory dryer at 110 °C for 1 
hour. The third group was sprayed with a visualization agent and left at room temperature 
until dry. The fourth group was sprayed with a visualization agent and dried for one hour 
in a laboratory dryer at 110 °C.
Spectrodensitometry and densitometry of chromatograms
Spectrodensitometry and densitometry were carried out with a Camag Scanner TLC 3 
operated in absorbance mode, fitted with a WinCATS 1.4.2 software. The detector system 
was a deuterium lamp emitting a UV spectrum in the range 190–450 nm and a tungsten 
lamp emitting a spectrum in the range 370–800 nm. The starting point was at 200 nm and 
the end wavelength was 800 nm. The slit dimensions were set at 10.00 ́  0.40 mm, the scanning 
speed of 20 nm s–1 and the data resolution of 1 nm per step were used for the spectrodensi-
tometric analysis. Densitometric scanning was conducted at the respective absorption 
maximum (Table I). The slit dimensions were set at 10.00 ´ 0.40 mm, the scanning speed of 
20 mm s–1 and the data resolution at 100 µm per step were suitable for densitometric analysis. 
This was done in triplicate and baseline correction was employed.
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Limit of detection (LOD) and limit of quantification (LOQ)











where S is the slope of the calibration line and σ standard deviation of the response. σ was 
determined by using the standard deviation of the intercept (Y) of the calibration plot (sa) 
and the residual standard deviation of the regression line (sxy). LOD and LOQ values were 
calculated from the results obtained by both criteria.
Statistical analysis




The influence of mobile phase composition and the kind of the sorbent on the limit of 
detection and quantification of meloxicam was estimated. The most commonly used chroma-
Table I. Spectrodensitometric characteristics of meloxicam on different chromatographic plates after UV detection
TLC plate Main absorption band λmax (nm)a
Additional absorption bands


























a Intensity of all absorption maxima is equal to 95 AU.
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tographic plates were selected as the stationary phases. The mobile phases were selected 
so that meloxicam travel properly either in NP-TLC or RP-TLC.
During methods optimization several mobile phases were tested; finaly, the following 
were chosen: ethyl acetate/toluene/n-butylamine (2:2:1, V/V/V) (mobile phase I), ethyl ace-
tate/ethanol/toluene/25 % NH4OH (6:3:1: 0.06, V/V/V/V) (mobile phase II), methanol/water 
(5:5, V/V) (mobile phase III) and methanol/water (8:2, V/V) (mobile phase IV).
Detection of meloxicam without visualization agents
Meloxicam was detected firstly in UV without the use of visualization agents on different 
chromatographic plates. The resultant spectrodensitograms of meloxicam described in Table I 
indicate that the applied sorbents influenced the wavelength of the absorption peak (λmax) 
and the additional absorption bands as well as their intensity [AU]. In NP-TLC analysis, the 
fundamental band of meloxicam shifts from 361 to 369 nm, and three additional absorption 
bands were observed. However, by using Al2O3 150F254 plates, only two additional bands for 
meloxicam were noticed on its spectrodensitogram. In the case of RP-TLC plates, the funda-
mental bands of meloxicam occur at 213 nm and 215 nm, for SiO2 RP-18F254 and SiO2 RP-8F254, 
respectively. The chromatographic plates influenced the meloxicam spectra markedly. This 
Table II. Limit of detection (LOD) of meloxicam obtained by NP-TLC and RP-TLC methods after UV 
detection
Mobile phasea Sorbentb RF valuec
LOD (µg per spot) 
calculated usingd
Average value of 
LOD (µg per spot)c
sa sxy
I
Al2O3 60F254 0.73 ± 0.05 0.098 0.034 0.066 ± 0.035
Al2O3 150F254 0.75 ± 0.04 0.090 0.070 0.080 ± 0.011
SiO2 60 0.59 ± 0.05 0.158 0.054 0.106 ± 0.057
SiO2 60F254 0.58 ± 0.05 0.074 0.052 0.063 ± 0.012
SiO2 60/KG F254 0.70 ± 0.05 0.266 0.074 0.170 ± 0.105
II
Al2O3 60F254 0.07 ± 0.02 0.164 0.067 0.116 ± 0.053
Al2O3 150F254 0.28 ± 0.03 0.220 0.051 0.136 ± 0.093
SiO2 60 0.80 ± 0.05 0.097 0.063 0.080 ± 0.019
SiO2 60F254 0.75 ± 0.05 0.042 0.027 0.035 ± 0.008
SiO2 60/KG F254 0.73 ± 0.05 0.211 0.059 0.135 ± 0.083
III
SiO2 RP-18F254 0.48 ± 0.03 0.115 0.075 0.095 ± 0.022
SiO2 RP-8F254 0.38 ± 0.03 0.194 0.088 0.141 ± 0.058
IV
SiO2 RP-18F254 0.90 ± 0.03 0.133 0.031 0.082 ± 0.056
SiO2 RP-8F254 0.80 ± 0.03 0.112 0.051 0.082 ± 0.033
Rf – retention factor, LOD – limit of detection; a Mobile phase I: ethyl acetate/toluene/n-butylamine (2:2:1, V/V/V), II: 
ethyl acetate/ethanol/toluene/25 % ammonium hydroxide (6:3:1: 0.06, V/V/V/V), III: methanol/water (5:5, V/V), IV: 
methanol/water (8:2, V/V); b Sorbent Al2O3 60F254 – neutral aluminum oxide 60F254, Al2O3 150F254 – neutral aluminum 
oxide 150F254, SiO2 60 – silica gel 60, SiO2 60F254 – silica gel 60F254, SiO2 60/KG F254 – mixture of silica gel 60 and Kie-
selghur F254, SiO2 RP-18F254 – silica gel RP-18F254s, SiO2 RP-8F254 – silica gel RP-8F254s; c Mean ± SD), n = 6; dsa – standard 
deviation of the intercept (a) of calibration curve, sxy – residual standard deviation of a calibration curve.
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might be explained by the physical and physicochemical properties of the chromatographic 
plates. This fact points to the need for standardization of chromatographic conditions during 
spectrodensitometric investigations of meloxicam.
LODs of meloxicam obtained by NP-TLC and RP-TLC on different chromatographic 
sorbents and by using four proposed mobile phases are presented in Table II, showing also 
the RF values of meloxicam achieved under particular chromatographic conditions. As it 
is shown in Table II, NP-TLC analysis was performed using two mobile phases. For mobile 
phase I (ethyl acetate/toluene/n-butylamine (2:2:1, V/V/V), the lowest LOD (and consequently 
LOQ, LOQ = 3×LOD) values were obtained on neutral aluminum oxide 60F254 and silica gel 
60F254 plates. For mobile phase II (ethyl acetate/ethanol/toluene/25 % ammonia, 6:3:1:0.06; 
V/V/V/V), the lowest LOD (and LOQ) were achieved on silica gel 60F254 plate. Comparing 
the results obtained for both mobile phases in the NP-TLC system leads to the highest LOD 
Table III. Spectrodensitometric characteristics of meloxicam obtained on SiO2 60F254 and neutral Al2O3 
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276 70.4 237 51.3
292 71.1 276 57.7










794   5.8
a The intensity of all absorption maxima is equal to 95 AU.
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(and LOQ) achieved using mobile phase I and SiO2 60/KG F254 plates. Further, RP-TLC 
chromatographic analysis was also performed using two stationary phases and mobile 
phases consisting of methanol/water 5:5 (mobile phase III) and 8:2 (mobile phase IV). In 
this case, LOD (and LOQ) of meloxicam were very similar for both carriers, silica gel RP-18F254s 
and silica gel RP-8F254s, with mobile phase IV. In addition, values obtained using mobile 
phase IV were lower relative to the values obtained using mobile phase III.
Detection of meloxicam with visualization agents
Our earlier research (4) indicated that TLC coupled with densitometry on silica gel 60F254 
and neutral aluminum oxide 150F254 plates using ethyl acetate/toluene/n-butylamine mixture 
(2:2:1, V/V/V) as the mobile phase was suitable for the successful separation of meloxicam 
from the potential impurities. For this reason, the same experimental conditions (stationary 
phases and mobile phase) were applied as the optimum in this work. Eight visualization 
agents (known as dyes), namely, brilliant cresyl blue, alkaline blue, methylene violet, Janus 
blue, brilliant green, methyl green, gentian violet and crystalline violet were used to detect 
meloxicam. Rhodamine B and fuchsin were used as visualization agents for comparison.
Meloxicam spots obtained on silica gel 60F254 plates immediately after the use of an appro-
priate visualization agent were observed for all tested dyes except for fuchsin. After 60 min, the 
meloxicam spots were visible on the plates dried at room temperature when brilliant cresyl 
blue, methyl green, gentian violet, Janus blue, brilliant green and crystalline violet were applied. 
The spots obtained on the chromatographic plates dried in the laboratory dryer for 60 min were 
visible after the use of gentian violet, brilliant green, and crystalline violet. What is more, the 
meloxicam spots shown on the plates that were immersed in the visualization agents were more 
clearly visible than the spots on the plates sprayed with the same visualization agents. It was 
observed that the spots visible after immersion in Janus blue, methyl green, brilliant green, and 
gentian violet dried at room temperature and crystalline violet after drying in the laboratory 
dryer were the best for the analysis. The visual and densitometric evaluation of the chromato-
grams determined the choice of these visualization agents for further analysis of meloxicam 
(Table III). Figs. 1a-f show original photographs of chromatograms of meloxicam analyzed 
under applied chromatographic conditions and by using proposed visualization reagents.
Table IV summarizes the average values of LOD (and LOQ) of meloxicam and linearity 
range obtained on silica gel 60F254 (SiO2 60F254) and neutral aluminum oxide 150F254 (Al2O3 
150F254) plates after detection using the best visualization agents. It can be observed that in 
the case of chromatographic plates precoated with neutral Al2O3 150F254 the LOD values 
were the lowest without the use of a visualization agent (0.080 µg per spot). After the use of 
a proper visualization agent, the LOD value was for gentian violet 0.154 µg per spot and for 
Janus blue 0.192 µg per spot. Markedly higher LOD values were obtained using crystalline 
violet (0.394 µg per spot), brilliant green (0.697 µg per spot) as well as methyl green (0.706 µg 
per spot). The LOD of meloxicam on silica gel 60F254 as the stationary phase was the lowest 
in the absence of a visualization agent and it was 0.063 µg per spot. Desain and Amin (6) 
reported a similar meloxicam LOD value on HPTLC plates (LOD 0.090 µg per spot). How-
ever, the best LOD of meloxicam on silica gel 60F254 HPTLC plates of 0.023 µg per spot was 
obtained by Shaji and Varkey (9). Starek and Krzek (5) reported that LOD for meloxicam on 
silica gel 60F254 is equal to 0.096 µg per spot. Moreover, it has been shown that by dipping in 
Janus blue, gentian violet, methyl green, and brilliant green and drying at room tempera-
ture, as well as dipping in crystalline violet and drying in the laboratory dryer, allow the 
identification of meloxicam due to the chromatographic spot color.
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Fig. 1. Photographs of chromatograms of meloxicam analyzed on: a) Al2O3 150F254 and detected using 
Janus blue, b) SiO2 60F254 and detected using Janus blue, c) Al2O3 150F254 and detected using crystalline 
violet, d) SiO2 60F254 and detected using crystalline violet, e) Al2O3 150F254 and detected using brilliant 
green, f) SiO2 60F254 and detected using brilliant green.
Table IV. Average values of the limit of detection (LOD) of meloxicam and linearity range obtained on SiO2 
60F254 and neutral Al2O3 150F254 plates after detection using the best visualization agents
Detection method Sorbent
Average value of 





SiO2 60F254 0.063 ± 0.012 0.2–5.0  (R = 0.989)
Al2O3 150F254 0.080 ± 0.011 0.3–5.0  (R = 0.992)
Janus blue
SiO2 60F254 0.272 ± 0.058 1.0–7.0  (R = 0.995)
Al2O3 150F254 0.192 ± 0.089 0.7–6.0  (R = 0.992)
Gentian violet
SiO2 60F254 0.436 ± 0.074 2.0–7.0  (R = 0.993)
Al2O3 150F254 0.154 ± 0.019 0.5–5.0  (R = 0.991)
Brilliant green
SiO2 60F254 0.149 ± 0.097 0.5–5.0  (R = 0.995)
Al2O3 150F254 0.697 ± 0.146 3.0–7.0  (R = 0.996)
Methyl green
SiO2 60F254 0.387 ± 0.112 2.0–8.0  (R = 0.993)
Al2O3 150F254 0.706 ± 0.135 2.5–8.0  (R = 0.993)
Crystalline violet
SiO2 60F254 0.105 ± 0.089 0.4–5.0  (R = 0.994)
Al2O3 150F254 0.394 ± 0.113 2.0–7.0  (R = 0.990)
LOD – limit of detection, R – coefficient of correlation
a Mean ± SD, n = 6.
a)         b)         c)         d)           e)        f)
 8 mm    8 mm   8 mm    8 mm     8 mm   8 mm
What is important, the lowest value of LOD for meloxicam was obtained on two applied 
sorbents without the use of any visualization agent. Of all visualization agents tested, the 
lowest detection limit of meloxicam was obtained using crystalline violet and gentian violet 
on silica gel 60F254 and neutral aluminum oxide 150F254, resp.
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The obtained spectrodensitograms of meloxicam indicate that applied visualization 
agents and the type of chromatographic plate can influence the wavelength of the obtained 
fundamental absorption band (lmax) and the additional absorption bands as well as their 
intensity values [AU]. The specific surface area of the stationary phase, its chemical compo-
sition/modification, the presence of a fluorescent additive, and other physicochemical charac-
teristics affect the meloxicam spectra.
Generally, accurate and rapid identification of meloxicam as an API might rely on 
comparison with the spectrum of the reference standard. This might be assessed on silica 
gel 60F254 and neutral aluminum oxide 150F254 plates without the use of a visualization 
agent or after using gentian violet (Figs. 2a–d).
CONCLUSIONS
Based on the presented results, it can be concluded that the optimization of chromato-
graphic conditions including the type of sorbent as well as modifying the mobile phase 
composition may significantly improve the LOD and LOQ values of meloxicam. The best 
sensitivity of developed TLC-densitometric method in the NP-TLC system was obtained on 
neutral aluminum oxide 60F254 and silica gel 60F254 plates by using the mixture of ethyl 
acetate/toluene/n-butylamine (2:2:1, V/V/V) as the mobile phase. However, in the case of RP-
TLC, the best results for LOD and LOQ were achieved on silica gel RP-8F254 and RP-18F254 
plates using a mixture of methanol/water (8:2, V/V) as the mobile phase.
Fig. 2. A spectrum of meloxicam on: a) silica gel 60F254 without the use of visualization agent, b) silica 
gel 60F254 after detection with gentian violet, c) neutral aluminum oxide 150F254 without the use of 
visualization agent, d) neutral aluminum oxide 150F254 after detection with gentian violet.
a)                                                                 c)
 
b)                                                                 d)
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Of all visualization agents tested, the lowest detection limit of meloxicam enabled 
crystalline violet and gentian violet as new visualization agents on silica gel 60F254 and 
neutral aluminum oxide 150F254, resp. Thus, the developed TLC-densitometric method may 
be successfully applied for the detection of meloxicam at low LOD and LOQ range (µg per 
spot). What is more, the colored spots and spectrodensitograms of meloxicam obtained by 
using an individual visualization reagent might possibly be auxiliary tools for the identifi-
cation of meloxicam.
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